Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Peer Reviewed
See detailGlossaire
Hoffsummer, Patrick ULiege; Touzé, Rachel

in Hoffsummer, Patrick (Ed.) Les charpentes du XIe au XIe au XIXe siècle: Grand Ouest de la France: typologie et évolution: analyse de la documentation de la Médiathèque de l'architecture et du patrimoine (2011)

This french glossay is a complement to these published in and 2009 in Archiectura mediiaevi 3

Detailed reference viewed: 15 (2 ULiège)
See detailGlossaire
Hoffsummer, Patrick ULiege; Prévet, Alain

in Hoffsummer, Patrick (Ed.) Les charpentes du XIe au XIXe siècle: typologie et évolution en France du Nord et en Belgique (2002)

Detailed reference viewed: 8 (0 ULiège)
Full Text
Peer Reviewed
See detailUn glossaire naturaliste au second degré ? À propos de La Flore pornographique d’Ambroise Macrobe
Saint-Amand, Denis ULiege

in Cahiers Naturalistes : Bulletin officiel de la Société Littéraire des Amis d'Emile Zola (2013), 87

Publié en 1883, La Flore pornographique. Glossaire de l’école naturaliste se présente comme un outil destiné à livrer les clefs d’une littérature recourant fréquemment à la « langue verte » pour mieux en ... [more ▼]

Publié en 1883, La Flore pornographique. Glossaire de l’école naturaliste se présente comme un outil destiné à livrer les clefs d’une littérature recourant fréquemment à la « langue verte » pour mieux en dénoncer l’obscénité. Cet article tente d’apporter un éclairage neuf sur ce cas particulier, en en interrogeant la structure et les logiques et en cherchant à mesurer s’il ne convient pas de le lire en réalité comme une satire de la critique antinaturaliste. [less ▲]

Detailed reference viewed: 42 (6 ULiège)
See detailGlossaire toponymique de la commune de Saint-Léger
Kurth, Godefroid ULiege

in Fédération archéologique et historique de Belgique (Ed.) Compte rendu des travaux du congrès (1887)

Detailed reference viewed: 24 (0 ULiège)
See detailGlossaires pour rire ou Le lexique comme style.
Saint-Amand, Denis ULiege

Conference (2010, March 20)

Detailed reference viewed: 10 (2 ULiège)
Full Text
See detailLes glossaires toponymiques
Kurth, Godefroid ULiege

in Fédération archéologique et historique de Belgique (Ed.) Compte rendu des travaux du congrès (1887)

Detailed reference viewed: 17 (3 ULiège)
Full Text
Peer Reviewed
See detailI glossari e gli inventari tre-quattrocenteschi: piccoli grandi tesori di lessico (e cultura) materiale
Aresti, Alessandro ULiege

in Adamo, Stefano; Nobili, Claudio (Eds.) La capsula del tempo. Aspetti selezionati di lingua, letteratura e cultura italiana da conservare in prospettiva futura (2017)

Detailed reference viewed: 25 (11 ULiège)
Full Text
Peer Reviewed
See detailUn glossario alfabetico di voci volgari da lessici medievali italoromanzi (II)
Aresti, Alessandro ULiege

in Bollettino dell'Atlante Lessicale degli Antichi Volgari Italiani (2013), 6

Detailed reference viewed: 19 (3 ULiège)
Full Text
Peer Reviewed
See detailUn "Glossario dei glossari" degli antichi volgari italiani: preliminari, risultati, prospettive
Aresti, Alessandro ULiege

in Bollettino dell'Atlante Lessicale degli Antichi Volgari Italiani (2010), 3

Detailed reference viewed: 27 (1 ULiège)
Full Text
Peer Reviewed
See detailUn glossario di voci volgari da lessici medievali italoromanzi (I)
Aresti, Alessandro ULiege

in Bollettino dell'Atlante Lessicale degli Antichi Volgari Italiani (2012), 5

Detailed reference viewed: 18 (5 ULiège)
See detailGlossary for the English Edition
Alcock, Nathaniel W.; Courtenay, Lynn T.; Currie, Christopher et al

in Hoffsummer, Patrick (Ed.) Roof Frames from the 11th to the 19th Century: Typology and Development in Northern France and in Belgium: Analysis of CRMH Documetnation (2009)

Detailed reference viewed: 6 (0 ULiège)
See detailGlossematica e semiotica: loro espansioni
Galassi, Romeo; Zorzella, Cristina; Cigana, Lorenzo ULiege

Book published by ZeL Edizioni (2012)

Collection of contribution on Hjelmslev's Glossematics

Detailed reference viewed: 26 (1 ULiège)
Full Text
Peer Reviewed
See detailGlossopharyngeal neuralgia triggered by non-noxious stimuli at multiple cephalic and extracephalic sites.
ter Berg, J. W. M.; Dupont, P.; Schoenen, Jean ULiege

in Cephalalgia : An International Journal of Headache (2009), 29(11), 1174-9

Glossopharyngeal neuralgia (GN) triggered by non-noxious stimuli at multiple cephalic and extracephalic sites with positron emission tomography (PET) evidence for involvement of the upper brainstem has ... [more ▼]

Glossopharyngeal neuralgia (GN) triggered by non-noxious stimuli at multiple cephalic and extracephalic sites with positron emission tomography (PET) evidence for involvement of the upper brainstem has never been reported. We present such a patient, a 73-year-old man who since the age of 50 had suffered from GN with a high recurrence rate and very severe unilateral, non-familial GN episodes with very easy trigger zones widely extending beyond the n IX territory. Extensive neuroimaging and neurophysiological tests detected no precise underlying cause. PET scan revealed activation in the upper brainstem on extracephalic triggers. Single-fibre electromyography data will be discussed. We hypothesize that deficient inhibition as seen in trigeminal nociceptive reflexes on the level of brainstem interneurons, a functional lesion in the primary somatosensory cortex-sensory thalamic nuclei circuit and the dorsal column-thalamic pathway both activated by light touch may in part be involved in the extracephalic triggering. [less ▲]

Detailed reference viewed: 40 (0 ULiège)
Full Text
Peer Reviewed
See detailGlottoplasty for Male-to-Female Transsexualism: Voice Results
Remacle, Marc; Matar, Nayla; Morsomme, Dominique ULiege et al

in Journal of Voice (2010), 25(1), 120-3

Summary: Objectives. The aim of this study was to evaluate the objective voice results ofWendler’s glottoplasty in male-to-female transsexuals. Method. We retrospectively reviewed our patients treated ... [more ▼]

Summary: Objectives. The aim of this study was to evaluate the objective voice results ofWendler’s glottoplasty in male-to-female transsexuals. Method. We retrospectively reviewed our patients treated with Wendler’s technique with minor modifications. Glottoplasty consisted in CO2-laser epithelial ablation of the anterior commissure and the two vocal folds in anterior third, suturing of the two vocal folds with two stitches of 3.0 resorbable thread, and application of fibrin sealant to strengthen the suture. Voice assessment was based mainly on fundamental frequency (F0), frequency range, jitter, maximum phonation time, phonation quotient, estimated subglottic pressure (ESGP) grade of dysphonia (G), and voice handicap index (VHI). These measures were taken before surgery and on the last follow-up visit. Results. Our series included 15 patients with a mean age of 36 years. The mean follow-up period was 7.2 months.We did not observe any early complications related to the technique. The comparison between the preoperative and the postoperative measurements, using Wilcoxon signed rank test, showed a significant improvement of median F0 from 139 to 191 Hz (P ¼ 0.006) with an increase in the grade of dysphonia (Gpre ¼ 0.2, Gpost ¼ 1, P ¼ 0.013) and ESGP (ESGPpre ¼ 8.1 ± 3.2, ESGPpost ¼ 12.0 ± 3.8, P ¼ 0.002). Other measurements, including VHI, did not show any significant differences pre- and postoperatively. Conclusion. Wendler’s glottoplasty can contribute to feminize the voice. [less ▲]

Detailed reference viewed: 164 (4 ULiège)
Full Text
Peer Reviewed
See detailGLP-1 receptor agonists and heart failure in diabetes.
Scheen, André ULiege

in Diabètes & Métabolism (2017), 43 Suppl 1

The prevalence of heart failure (HF) is increasing in patients with type 2 diabetes (T2D), and glucose-lowering agents have distinctive effects on the risk of developing HF that requires hospitalization ... [more ▼]

The prevalence of heart failure (HF) is increasing in patients with type 2 diabetes (T2D), and glucose-lowering agents have distinctive effects on the risk of developing HF that requires hospitalization. Such an increased risk has been consistently reported with thiazolidinediones (glitazones) and perhaps also with the dipeptidyl peptidase (DPP)-4 inhibitor saxagliptin (at least in SAVOR - TIMI 53), whereas a markedly decreased risk was highlighted with the sodium - glucose cotransporter type 2 (SGLT2) inhibitor empagliflozin in EMPA-REG OUTCOME. Yet, the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on myocardial function remain controversial. Whereas some promising observations have been reported in various animal models, the effects of GLP-1RAs on myocardial function in humans are more heterogeneous, while the positive effect on left ventricular ejection fraction (LVEF), if any, appears to be inconsistent and rather modest in most patients with HF. However, no increased risk of hospitalization for HF has been reported with GLP-1RAs in meta-analyses of phase-II/III trials (exenatide, albiglutide, dulaglutide, liraglutide), demonstrating the safety of this pharmacological class, and such findings have been confirmed by three large prospective cardiovascular outcome trials (ELIXA with lixisenatide, LEADER with liraglutide and SUSTAIN-6 with semaglutide). In particular, LEADER reported a trend towards a reduction in HF hospitalization (-13%, P = 0.14), together with a significant reduction in cardiovascular and all-cause mortality in patients with T2D at risk of cardiovascular disease. These results are reassuring in the face of the somewhat negative results of the FIGHT trial, which evaluated the effects of liraglutide in patients with advanced HF and low LVEF, such that further studies and caution are now required when using this agent to treat such patients in clinical practice. [less ▲]

Detailed reference viewed: 290 (2 ULiège)
Full Text
Peer Reviewed
See detailGLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician?
SCHEEN, André ULiege

in Annales d'Endocrinologie (2013)

Pharmacological treatment of type 2 diabetes has been enriched during recent years, with the launch of incretin therapies targeting glucagon-like peptide-1 (GLP-1). Such medications comprise either GLP-1 ... [more ▼]

Pharmacological treatment of type 2 diabetes has been enriched during recent years, with the launch of incretin therapies targeting glucagon-like peptide-1 (GLP-1). Such medications comprise either GLP-1 receptor agonists, with short (one or two daily injections: exenatide, liraglutide, lixisenatide) or long duration (one injection once weekly: extended-released exenatide, albiglutide, dulaglutide, taspoglutide); or oral compounds inhibiting dipeptidyl peptidase-4 (DPP-4), the enzyme that inactives GLP-1, also called gliptins (sitagliptin, vildagliptin, saxagliptin, linagliptin, alogliptin). Although both pharmacological approaches target GLP-1, important differences exist concerning the mode of administration (subcutaneous injection versus oral ingestion), the efficacy (better with GLP-1 agonists), the effects on body weight and systolic blood pressure (diminution with agonists versus neutrality with gliptins), the tolerance profile (nausea and possibly vomiting with agonists) and the cost (higher with GLP-1 receptor agonists). Both agents may exert favourable cardiovascular effects. Gliptins may represent a valuable alternative to a sulfonylurea or a glitazone after failure of monotherapy with metformin while GLP-1 receptor agonists may be considered as a good alternative to insulin (especially in obese patients) after failure of a dual oral therapy. However, this scheme is probably too restrictive and modalities of using incretins are numerous, in almost all stages of type 2 diabetes. Physicians may guide the pharmacological choice based on clinical characteristics, therapeutic goals and patient's preference. [less ▲]

Detailed reference viewed: 131 (0 ULiège)
Peer Reviewed
See detailGlucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
Scheen, André ULiege; Castillo, M. J.; Lefebvre, Pierre ULiege

in Diabètes & Métabolism (1996), 22(6), 455-8

Detailed reference viewed: 31 (0 ULiège)
Full Text
Peer Reviewed
See detailLe glucagon-like peptide-1 (GLP-1), nouvelle cible dans le traitement du diabete de type 2.
Scheen, André ULiege

in Revue Médicale de Liège (2007), 62(4), 217-21

Glucagon-like peptide-1 (GLP-1) is a gut hormone secreted in response to the ingestion of a meal. It exerts various favourable metabolic effects among which a glucose-dependent stimulation of insulin ... [more ▼]

Glucagon-like peptide-1 (GLP-1) is a gut hormone secreted in response to the ingestion of a meal. It exerts various favourable metabolic effects among which a glucose-dependent stimulation of insulin secretion, an inhibition of glucagon secretion, a slow down of gastric emptying, and a central anorectic effect. In rodents, a protective effect, or even a trophic effect, on B cell has also been reported. Interestingly, GLP-1 secretion is decreased in patients with type 2 diabetes. This observation stimulated the pharmaceutical research with the aim of restoring appropriate GLP-1 circulating levels able to exert the numerous positive effects of the hormone. One of the main objectives was to solve the problem due to the very short half-life of GLP-1. We here briefly describe the main two proposed approaches : ether to subcutaneously inject an incretinomimetic agent closed to GLP-1 (exenatide) or a long-acting GLP-1 analogue (liraglutide), both being partially resistant to the action of dipeptidylpeptidase-IV (DPP-IV), either to orally administer a selective DPP-IV inhibitor, an enzyme metabolising endogenous GLP-1 (sitagliptin, vildagliptin, .... These new drugs offer the advantage of improving blood glucose control of type 2 diabetic patients, without inducing severe hypoglycaemia and without promoting weight gain (instead a weight reduction is generally observed). These agents should occupy a key place in the overall pharmacological strategy of type 2 diabetes in a near future, especially if the additional favourable effects on B cells are confirmed in clinical practice. [less ▲]

Detailed reference viewed: 1404 (5 ULiège)
Full Text
Peer Reviewed
See detailThe glucocorticoid receptor inhibits the human prolactin gene expression by interference with Pit-1 activity
Nalda, Asunción M; Martial, Joseph ULiege; Muller, Marc ULiege

in Molecular & Cellular Endocrinology (1997), 134(2), 129-37

Glucocorticoids have been shown to inhibit the activity of the human prolactin (hPRL) promoter. Using transient expression experiments in rat pituitary cells, we located the sequence conferring ... [more ▼]

Glucocorticoids have been shown to inhibit the activity of the human prolactin (hPRL) promoter. Using transient expression experiments in rat pituitary cells, we located the sequence conferring glucocorticoid inhibition to a region which contains Pit-1 binding sites, responsible for pituitary-specific expression, but does not seem to contain a glucocorticoid receptor (GR) binding site. Co-transfection experiments in non-pituitary cell lines, using expression vectors for Pit-1 and different mutants of the human GR show that inhibition of the hPRL gene is seen only in the presence of Pit-1 and GR, and that the DNA binding function of the receptor is not required. Immunoprecipitation studies show that either anti-GR or anti-Pit-1 antibodies are able to co-precipitate GR and Pit-1, suggesting an interaction between these factors. We conclude that the activated GR functionally interferes with the pituitary specific factor Pit-1, thereby leading to the observed transcriptional repression. [less ▲]

Detailed reference viewed: 36 (3 ULiège)
Full Text
Peer Reviewed
See detailThe glucocorticoid receptor.
Muller, Marc ULiege; Renkawitz, R.

in Biochimica et Biophysica Acta (1991), 1088

Detailed reference viewed: 18 (1 ULiège)